MedTrace Logo

Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS

NCT03717935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2025-03-24

Study results available
· View outcomes & findings →

Summary

The Investigators will measure hepatic glucose and fat metabolism in obese girls with Polycystic Ovarian Syndrome (PCOS) and hepatic steatosis (HS) after taking 4 weeks of an essential amino acid (EAA) supplement or placebo and test whether the EAA supplement can improve hepatic glucose metabolism in these girls.

Conditions

  • Polycystic Ovarian Syndrome
  • Obesity
  • Hepatic Steatosis

Interventions

DIETARY_SUPPLEMENT

Essential Amino Acid (EAA) Supplement

Powder supplement

OTHER

Placebo

Powder that will be similar to the essential amino acid supplement

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Melanie Cree-Green, MD, PhD · Department of Endocrinology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2022-01-14
Completion
2022-01-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03717935 on ClinicalTrials.gov